J&J completes $3.05B Halda Therapeutics acquisitionBy jay.trebleDecember 29, 2025Listen to this article Johnson & Johnson finalized its $3.05 billion acquisition of clinical-stage biotech Halda Therapeutics OpCo. Inc. In a Dec. 29 press release announcing…
3
4
5
